申请人:University of Louisville Research Foundation, Inc.
公开号:US20210137939A1
公开(公告)日:2021-05-13
A compound for use in treating a disease associated with activating mutations in RAS, or for use in treating a disease treatable by a reduction in RAS activity, is selected from a compound of Formula (I), salts and esters thereof. The compounds are particularly useful in treating cancer.